Intrathecal Levobupivacaine With Opioids for Caesarean Section

NCT01858090 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 93

Last updated 2013-05-21

No results posted yet for this study

Summary

In this prospective, randomized, double-blind, controlled study, the aim was to compare the effect of adding fentanyl (10 µg) or sufentanil (2.5 µg) to levobupivacaine (2.2±0.2 ml 0.5%) on the intraoperative anesthesia quality, block characteristics, the side effects on the newborn and mother, the duration of postoperative analgesia, and surgeon satisfaction score.

Conditions

  • Elective Caesarean Section Surgeries

Interventions

DRUG

Control Group Chirocaine

Control group: Spinal anesthesia with levobupivacaine+Serum Physiologic %0.9 (Total volume 3 mL)

DRUG

Group Fentanyl

DRUG

Group sufentanil

DRUG

Ephedrine

If systolic blood pressure values decreased more than 20% with respect to the baseline values, or decreased to \<100 mmHg, fluid loading and ephedrine (5 mg) were administered.

DRUG

Atropine sulfate

A decrease in heart rate to less than 55 beats/min was considered as bradycardia, and atropine (0.5 mg) was administered

DRUG

Propofol

Intravenous propofol (up to 0.5 mg/kg) was administered if patients had discomfort

DRUG

Metoclopramide

Metoclopramide (10 mg IV) was administered for nausea

DRUG

Diphenhydramine

for severe pruritus

DRUG

pethidine hydrochloride

pethidine hydrochloride (50 mg IM) was administered as the first analgesic postoperatively

DRUG

Diclofenac sodium

as additional analgesic among cases in which VAS\>3(Postoperatively)

Sponsors & Collaborators

  • Baskent University

    lead OTHER

Principal Investigators

  • Anis Aribogan, Prof., MD · Baskent University School of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2009-10-31
Completion
2010-01-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01858090 on ClinicalTrials.gov